Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

European Commission Approves DAYBU® (Trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms Associated with Rett Syndrome in the European Union

recognizes the significant unmet medical need in this rare disease. It provides clinicians with a new treatment option to help address the neurobehavioral symptoms of Rett syndrome and represents progress for the Rett community.” With this...

Dunbar Pharma Brings First Plant-Derived Dronabinol API to the UK Market Through IPS Pharma

to quality and reliability gives us confidence in the supply of regulated cannabinoid medicines. Together, we're helping improve access to high-quality oral treatment options for clinicians prescribing under the UK's Specials framework.” Dunbar...

Former DePuy Synthes U.S. President Joins Peptilogics Board

had against device-related infections is more surgery. We are aiming to change that with zaloganan, and Tim is going to help us change it," said Jonathan Steckbeck, Ph.D., CEO of Peptilogics. "He's led billion-dollar launches at the largest...

Neurolief Advances Veteran Mental Health and Migraine Care With New VA Contract for Prescription Neuromodulation

for years, moving from one antidepressant to the next without relief, and many have lost hope that anything will help," said Mark George, M.D., a world expert in brain stimulation and depression and distinguished professor of psychiatry, radiology...

AVANTIK Appoints Jeffrey Waldman as Chief Executive Officer

he supported a comprehensive search for the company's next leader and will continue as an advisor through year-end to help ensure a seamless transition. "It has been a privilege to lead Avantik alongside a team I deeply respect. This is the right...

BioVigil Reaches 1 Billion Hand Hygiene Opportunities, Marking a Major Milestone in Patient Safety and Infection Prevention

occur. Why verified hand hygiene matters Each verified hand hygiene opportunity represents a moment when a caregiver can help interrupt the spread of infection and protect a patient, colleague or visitor. At scale, those moments create the...

Bruker Announces Majority Stake in MIMETAS to Accelerate Drug Discovery and Development Using Human Physiology-Relevant Models

Through its proprietary OrganoPlate® platform, the company provides predictive human tissue and disease models that help pharmaceutical and biotechnology companies improve decision making across the R&D pipeline, from target validation and disease...

U.S. FDA Accepts sBLA for ENFLONSIA™ to Expand RSV Indication to High-Risk Children Under Two

Development, Merck Research Laboratories. “The recent FDA and EMA regulatory filings represent important opportunities to help expand protection with ENFLONSIA for vulnerable children under two years of age during their second RSV season –...

Dallas-Based Microbiome Brand resbiotic® Comes Home to Texas with Launch at H-E-B

resbiotic as a brand rooted in microbiome science to produce research-backed, physician-formulated supplements that help people to live fuller, healthier lives. "This launch is especially meaningful for us," said Dr. C. Vivek Lal, founder and CEO...

US Capital Global Securities Announces $20 Million Offering for Thplasma to Invest in the Future of Plasma Therapeutics

regulatory approvals, and built the operational infrastructure necessary to support future growth. This financing will help advance our IVIG development program and position us to participate more fully in the expanding plasma therapeutics market.”...

EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.

reflects BD's deep expertise in drug delivery systems design and manufacturing, supporting scalable solutions that can help meet rising demand for injectable therapies. "BD's partnership with EMS introduces a critical treatment option backed by...

Excedr Secures $25 Million in Growth Capital to Expand Its Life Sciences Equipment Leasing Platform

so that more scientists can access missioncritical equipment without tying up equity or working capital. This in turn helps improve patient outcomes across the life sciences and healthcare ecosystem." The transaction comes at an inflection point...

InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of the Worldwide Launch of Its Non-Injectable Peptide Platform

and a non-invasive delivery method. By combining rigorous science with a shelf-stable, travel-friendly platform, we're helping make advanced peptide solutions more accessible to both healthcare providers and consumers worldwide." Driven by nine...

FDA Clears Roche's cobas® BV/CV Assay, Enabling Fast and Highly Accurate Diagnosis of Vaginitis

condition is close to 50%, raising the risk of recurrence.7 "Compared to traditional methods, the cobas® BV/CV test can help improve diagnostic accuracy for women affected by vaginitis, addressing a critical need in women's health," said Brad...

China Approves Haisco's Class 1 Innovative Drug, Ciprocopan Succinate Tablets, Providing a New Treatment Option for Patients with PNH

AbbVie, Eli Lilly, and Nuvectis, across key areas such as oncology and autoimmune diseases. These collaborations are helping bring China-originated innovative medicines to international markets. China's innovative drug R&D capabilities are gaining...

Children's Hospital of Philadelphia Initiative Substantially Increases Naloxone Co-Prescribing When Prescribing Outpatient Opioids

pharmacy to monitor out-of-pocket costs, identify financial barriers, and improve affordability. Their work ultimately helped expand access to a Pennsylvania state discount program previously available only to adult patients. While this initiative...

BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia Accepted by the U.S. Food and Drug Administration

consensus guidelines recommending initiation of VOXZOGO as early as possible. First approved in 2021, VOXZOGO has helped more than 5,000 infants and children in more than 50 countries. Through our ongoing studies, BioMarin continues to evaluate...

Cannabix Technologies and Omega Laboratories Announce a DOT-Like Breath-Based Drug Testing Panel for Recent-Use Detection

marijuana, opiates and PCP. By validating these drug classes in breath, Omega is advancing a testing option designed to help employers, courts, criminal justice programs, treatment and recovery organizations, schools, and other safety-sensitive...

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

and obesity makes this access moment particularly important for eligible Medicare beneficiaries. We are committed to helping patients, caregivers, and healthcare professionals navigate this program with confidence." The Medicare GLP-1 Bridge is...

Johnson & Johnson Strengthens European Cardiac Care with the Introduction of the Dual Energy THERMOCOOL SMARTTOUCH SF Ablation Platform

bringing together mapping, intracardiac ultrasound, therapy technologies and clinical support solutions designed to help physicians navigate increasingly complex ablation procedures. Cardiovascular Solutions from Johnson & Johnson MedTech Across...